← All organizations
International Extranodal Lymphoma Study Group
Academic/HospitalWebsite ↗
Also known as: International Extranodal Lymphoma Study Group (IELSG) | International Extranodal Lymphoma Study Group/Oncology Institute of Southern Switzerland. Bellinzona | International Extranodal Lymphoma Study Group/Oncology Institute of Southern Switzerland (IOSI)
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2000Last known activity
Feb 29, 2024
Timeline
1990s
- Jun 1, 1997
International Extranodal Lymphoma Study Group— Founded
Drugs by trial phase (30 distinct, 22 trials)
Phase 3 (12 own, 0 via acquisition)
Indications
Recent trials (29)
- NCT05735834Lead sponsorPhase 3Feb 29, 2024
- NCT04646395Lead sponsorPhase 2Mar 15, 2021
- NCT04417166Lead sponsorPhase 2Jun 30, 2020
- NCT03697512Lead sponsorPhase 2Jun 15, 2019
- NCT03495960Lead sponsorPhase 2Oct 1, 2018
- NCT03031483Study directorPhase 2Apr 3, 2017
- NCT03031483Lead sponsorPhase 2Apr 3, 2017
- NCT02329080Lead sponsorPhase 2Dec 1, 2014
- NCT02531841CollaboratorPhase 3Jul 1, 2014
- NCT01808599Lead sponsorPhase 2Dec 1, 2013
- NCT01820910Lead sponsorPhase 2Mar 1, 2013
- NCT02853370Lead sponsorPhase 2Jul 1, 2012
- NCT01164267Lead sponsorPhase 2Mar 1, 2010
- NCT01011920Lead sponsorPhase 2Nov 1, 2009
- NCT00945724Lead sponsorPhase 2Apr 1, 2009
Details
- Founded
- Bellinzona, CH Jun 1, 1997
- Last known activity
- Feb 29, 2024